Discover Tempus AI's Q3 2025 record results—positive adjusted EBITDA, 25% projected growth, and major data deals.

Live Updates Live Coverage Updates appear automatically as they are published. Get The Best Tempus AI Live Earnings Coverage ...

Datavault AI believes this technology has the potential to extend into a Pharmaceutical Exchange platform, which could transform the pharmaceutical industry by enabling efficient, secure asset ...

Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with ...

ClickHouse leverages agentic analytics internally with LibreChat-and-ClickHouse-powered DWAINE (Data Warehouse AI Natural ...

The field of fish conservation is grappling with the complex challenges posed by human-modified landscapes. As habitats undergo rapid transformation due to ...

Whole-genome sequencing (WGS) of tumor and germline can generate actionable molecular insights that can guide precision medicine efforts in salivary gland cancer (SGC), according to a new study in JCO ...

Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

First study to evaluate HER2DX in a randomized trial focused exclusively on older individuals (aged 70-80 years). HER2DX independently predicts long-term survival outcomes in patients treated ...